Clinical Trial Update: Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating cemiplimab alone and in combination with RP1 for advanced cutaneous squamous cell carcinoma. The study is currently act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• Libtayo (cemiplimab)
• RP1

Snippet

Sponsor: Replimune, Inc. | Conditions: Cutaneous Squamous Cell Carcinoma, Advanced Cutaneous Squamous Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING